Advertisement

Biogen Idec Inc. has awarded 12 fellowships to universities and medical centers researching multiple sclerosis, as part of a program the company started in 2006 to further education in the therapeutic area that forms the core of Biogen’s business.

The Cambridge-based biotech company has previously awarded four grants per year. This year’s total funding is $900,000 and the program has invested a total of $2 million since inception.

SOURCE

Advertisement
Advertisement